Updated PREDICT tool for breast cancer prognostication outperforms existing model
The PREDICT prognostication and treatment tool was developed in 2010 to help guide decisions for patients with invasive early-stage breast cancer. […]
Read MoreAuthor: claireoliverharwood
2023 Drug approvals for FDA and EMA; oncology continues strongly in pole position
Whilst appropriate focus has been on the US FDA approving 55 new drugs for 2023, of which 20 are first-in-class, […]
Read More